Clinical Trial

KD Treatment for Super-refractory Status Epilepticus

Name: KD Treatment for Super-refractory Status Epilepticus — clinical trial record (NCT07496749)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KD

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of the study is to investigate to evaluate the efficacy and safety of ketogenic diet (KD) as an adjunctive therapy in patients with Super Refractory Status Epilepticus (SRSE) in the intensive care unit (ICU).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-22.

Trial Details

NCT Number	NCT07496749
Lead Sponsor	Xuanwu Hospital, Beijing
Conditions	Super-refractory Status Epilepticus
Enrollment	84 participants
Start Date	2025-10-20
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-15